Yariv Wine
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 2%
- Immunology top 5%
- Oncology
- Infectious Diseases top 10%
- Co-authors
- George GeorgiouBrandon J. DeKoskyJason J. LavinderAmihay FreemanAnna Vaisman‐MenteshFelix FrolowGregory C. IppolitoMatías Gutiérrez-González
- Topics
- Monoclonal and Polyclonal Antibodies Research (16 papers)T-cell and B-cell Immunology (10 papers)Enzyme Structure and Function (7 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Yariv Wine
32 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 741
- Radiology, Nuclear Medicine and Imaging 606
- Immunology 589
- Oncology 169
- Infectious Diseases 147
Countries citing papers authored by Yariv Wine
This map shows the geographic impact of Yariv Wine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yariv Wine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yariv Wine more than expected).
Fields of papers citing papers by Yariv Wine
This network shows the impact of papers produced by Yariv Wine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yariv Wine. The network helps show where Yariv Wine may publish in the future.
Co-authorship network of co-authors of Yariv Wine
This figure shows the co-authorship network connecting the top 25 collaborators of Yariv Wine. A scholar is included among the top collaborators of Yariv Wine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yariv Wine. Yariv Wine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 25 | |
| 5 | 14 | |
| 6 | 41 | |
| 7 | 25 | |
| 8 | 52 | |
| 9 | 173 | |
| 10 | 21 | |
| 11 | 7 | |
| 12 | 44 | |
| 13 | 11 | |
| 14 | 11 | |
| 15 | 52 | |
| 16 | 313 | |
| 17 | 14 | |
| 18 | 12 | |
| 19 | 36 | |
| 20 | 21 |
About Yariv Wine
Yariv Wine is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Endocrinology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), T-cell and B-cell Immunology (10 papers) and Enzyme Structure and Function (7 papers). The work is most often cited by research in Immunology (589 citations), Radiology, Nuclear Medicine and Imaging (606 citations) and Virology (58 citations). Yariv Wine has collaborated with scholars based in Israel, United States and France. Frequent co-authors include George Georgiou, Brandon J. DeKosky, Jason J. Lavinder, Amihay Freeman, Anna Vaisman‐Mentesh, Felix Frolow, Gregory C. Ippolito, Matías Gutiérrez-González, Andrew D. Ellington and Andrew P. Horton. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.